USPTO serial 99584741
ECHO
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CARR, PATRICK C
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ECHO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dustin Luettgen
201 Haskins Way5th FloorSouth San Francisco, CA 94080Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations and nucleic acids for the preparation of nucleic acid payloads for scientific and industrial purposes; nucleic acids being active chemical ingredients for use in the manufacture of therapeutics; chemical preparations in the nature of nucleic acids for use in therapeutic, biotechnology and nanotechnology research | ACTIVE | — |
| 005 | Gene therapy preparations, namely, biological preparations for the treatment of human diseases or disorders, namely, diseases of genetic or genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology; gene delivery platform, namely, biological delivery agents for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology | ACTIVE | — |
| 042 | Scientific and technological services, namely research and design in the field of nucleic acid research and development; scientific research in the field of nucleic acids therapy development; scientific research, development, analysis, design and development relating to nucleic acid based pharmaceutical drugs and therapies; research and development in the field of gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 24, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 24, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 11, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |